Abstract

Background: Thyroid dysfunction is due to Failure in compatibility with physiologic changes during pregnancy which leads to adverse maternal and foetal outcomes.There is an increased risk of complications like abortion, preterm delivery, pre-eclampsia, anemia, placental abruption, Post-partum haemorrhage in pregnant women with thyroid disorders. Foetal complications include intrauterine growth restriction, preterm babies, still birth and neonatal deaths. Thyroid dysfunction has its effects on both maternal and foetal outcomes.2 Aim & Objective: To assess the incidence of thyroid disorders in pregnancy and to interpret the maternal and foetal outcome. Methodology: The Prospective study was conducted for a period of two years in Obstetrics & Gynaecology department of Bharati Vidyapeeth University, Pune. The methodology were explained to women and valid informed written consent was recorded. The ethical clearance was obtained from ethical review committee of the tertiary centre.The patients with thyroid dysfunction on treatment/without treatment were followed up till delivery/abortion. The maternal and fetal outcome were studied. Results: Out of 498 pregnant women 33 (6.6%) had hypothyroidism and 3(0.6%)had hypothyroidism and 462(92.8%) were Euthyroid group. In all the three group majority of the babies were not requiring admission in NICU. In hypothyroid group, 39.39% had complication. In hyperthyroidism group, 66.67% had any complications. In Euthyroid group, 30.74% had complication. Complication rate was comparatively higher in hypothyroidism and hyperthyroidism group compared to Euthyroid group. There was no case of placental abruption in my study. Conclusion: Due to impact that the maternal thyroid disorders has on pregnancy outcomes, Prompt identification of thyroid disorders and timely initiation of treatment is essential.

• 1.   Thammiah, J. (2016) ‘Screening for thyroid disorders in pregnancy with TSH estimation’, International Journal of Reproduction, Contraception, Obstetrics and Gynecology. Medip Academy, pp. 1052–1055. doi: 10.18203/2320-1770.ijrcog20160856.
• 2.   Sahu MT, Das V, Mittal S, Agarwal A, Sahu M (2010). Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch. Gynecol. Obstetr. 281: 215-220.
• 3.   Stagnaro-Green A, Pearce E (2012). Thyroid disorders in pregnancy. Nat. Rev. Endocrinol. 8: 650-658.
• 4.   Ajmani SN, Aggarwal D, Bhatia P, Sharma M, Sarabhai V, Paul M. Prevalence of overt and subclinical thyroid dysfunction among pregnant women and its effect on maternal and fetal outcome. The Journal of Obstetrics and Gynecology of India. 2014 Apr 1;64(2):105-10.
• 5.   Medici M, Timmermans S, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VW, Hofman A, Hooijkaas H, de Rijke YB, Tiemeier H, BongersSchokking JJ, Visser TJ. Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study. The Journal of Clinical Endocrinology & Metabolism. 2013 Jan 1;98(1):59-66.
• 6.   Mahadik K, Choudhary P, Roy PK. Study of thyroid function in pregnancy, its feto-maternal outcome; a prospective observational study. BMC Pregnancy Childbirth. 2020 Dec 10;20(1):769. doi: 10.1186/s12884-020-03448-z. PMID: 33302910; PMCID: PMC7726876.
• 7.   Dhanwal DK, Bajaj S, Rajput R, Subramaniam KA, Chowdhury S, Bhandari R, et al. (2016). Prevalence of hypothyroidism in pregnancy: An epidemiological study from 11 cities in 9 states of India. Indian J. Endocrinol. Metab. 20: 387-390.
• 8.   Sreelatha S, et al. The study of maternal and fetal outcome in pregnant women with thyroid disorders. Int J Reprod Contracept Obstet Gynecol. 2017; 6(8):3507–3513. doi: 10.18203/2320-1770.ijrcog 20173473.
• 9.   Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol. 2006 Feb; 107(2 Pt 1):337-41. doi: 10.1097/01.AOG. 0000197991.64246.9a. PMID: 16449121.

Data Sharing Statement

Funding